Novacyt SA (EURONEXT:ALNOV)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ALNOV

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ALNOV

  • Market Cap€740.160m
  • SymbolEURONEXT:ALNOV
  • IndustryHealthcare
  • SectorDiagnostics & Research
  • Currency
  • ISINFR0010397232

Company Profile

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology testing. The company operates its business through two business segments: Corporate and Diagnostics and Molecular Products.The Corporate and Diagnostics segment corresponds to diagnostic activities in laboratories, and the manufacturing and distribution of reagents and kitsfor bacterial and blood tests. The Molecular Products segment represents the activities of Primerdesign, which designs, manufactures and distributes test kits for certaindiseases in humans, animals and food products.Novacyt SA develops and markets solutions in medical cytology. It offers portfolio of cancer and infectious disease diagnostics products and services. It has three reportable segment, Cytology, Diagnostics and Molecular Testing.

Latest ALNOV news

Currently there for this company. Visit our news hub for other news .